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Several virulent bacteria have the ability to manipulate the host cell actin cytoskeleton as part of their path-
ogenic strategy. These pathogens subvert the host cell actin polymerization machinery for various purposes
including motility within host cells, cell-to-cell spread, and to prevent phagocytic engulfment by professional
phagocytes. In contrast to intracellular pathogens, pathogenic Escherichia coli (including both enterohemor-
rhagic and enteropathogenic E. coli) subvert actin polymerization from an extracellular position to facilitate
adherence. This review summarizes recent data on the mechanisms by which pathogenic E. coli hijack
members of theWiskott-Aldrich syndrome protein family tomanipulate actin polymerizationwithin host cells,
including the novel, and surprisingly simple, mechanism recently revealed for the EspFu effector.Introduction
Enterohemorrhagic E. coli (EHEC) serotype O157:H7 is a food-
borne human pathogen that causes severe human diseases
including hemorrhagic colitis and hemolytic-uremic syndrome
(Nataro and Kaper, 1998). Enteropathogenic E. coli (EPEC) is
a closely related pathogen responsible for causing infantile
diarrhea, mainly in developing countries (Chen and Frankel,
2005). These two bacterial strains belong to a family of patho-
gens that colonize the gut epithelium via formation of distinct
histopathological attaching and effacing (A/E) lesions, which
are characterized by degeneration of the epithelial cell microvilli
and intimate bacterial attachment (Knutton et al., 1987). A/E
pathogens are unique in their ability to drive actin subversion,
because they alter host actin polymerization from an extracel-
lular position, unlike intracellular pathogens.
Actin is a major component of the cytoskeleton of eukaryotic
cells, and it is critical for the cell shape and cell motility as
well as many other cellular functions. The actin cytoskeleton
is formed by polymerization of globular actin (G-actin) into
filamentous actin (F-actin). This process is regulated by the
Arp2/3 complex (Borisy and Svitkina, 2000). The best character-
ized activators of the Arp2/3 complex are members of the
Wiskott-Aldrich syndrome protein (WASP) family, including
WASP, neural WASP (N-WASP), and WASP-family verprolin
homologous proteins (WAVEs) (Miki and Takenawa, 2003). All
WASP family members have a catalytic VCA domain at the
C terminus through which Arp2/3 complex is activated to
nucleate actin polymerization.
The proteins that mediate actin polymerization by EPEC and
EHEC are mainly encoded on a 35 kb chromosomal pathoge-
nicity island, designated the locus of enterocyte effacement
(LEE). During infection, EHEC and EPEC bind to eukaryotic intes-
tinal epithelial cells and deliver translocated intimin receptor (Tir)
into the cells via the type III secretion system (T3SS). Following
translocation, Tir is integrated into the host plasma membrane
where it adopts a hairpin loop topology in which both N and CStructermini are intracellular (Campellone and Leong, 2003). The
extracellular domain of Tir (the central region) acts as the
receptor for the bacterial adhesion protein intimin. Through its
intracellular N and C termini, Tir interacts with several host cell
cytoskeletal proteins. Despite homology between the Tir
proteins of EPEC and EHEC strains and the host cell compo-
nents, several studies have shown that actin polymerization
mediated by Tir/intimin clustering utilizes different signaling
cascades in EPEC and EHEC strains.
Actin rearrangement is a common target exploited by different
pathogens for essential functions such as attachment, internali-
zation, and inter/intracellular motility (Bhavsar et al., 2007). In this
review, we discuss recent progress in our understanding of the
mechanisms bywhich E. coli hijackmembers of theWASP family
to stimulate the actin nucleation factor, the Arp2/3 complex.
Regulation of Actin Polymerization by WASP/N-WASP
Many basic cellular processes, including cell migration and
vesicle movement, require rapid induction of actin polymeriza-
tion. Nucleation of actin to form new filaments often occurs by
activation of the Arp2/3 complex, which is a stable complex of
seven proteins, including two actin-related proteins (Arp2 and
Arp3). The complex binds to existing actin filaments and induces
polymerization of actin to form a branching filament network
(Higgs and Pollard, 2001). The Arp2/3 complex has a very low
actin-nucleation activity on its own, but it can be activated by
members of the WASP family. These include WASP, which is
expressed in hematopoietic cells, N-WASP, and WAVE, which
are both widely expressed (Miki and Takenawa, 2003). WASP
and N-WASP proteins possess the same functional domains
and motifs including an N-terminal WASP homology 1 (WH1)
domain, which can bind phosphatidylinositol 4, 5-bisphosphate
(PIP2) and the WASP interacting protein (WIP), a regulatory
GTPase-binding domain (GBD) that includes a Cdc42/Rac-
interacting binding (CRIB) motif and a basic sequence for PIP2
binding, and a proline-rich region that can interact with SH3ture 17, January 14, 2009 ª2009 Elsevier Ltd All rights reserved 15
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Minireviewdomains and Profilin (Figure 1A). The C termini of all three pro-
teins contain a catalytic domain, termed verproline- homology,
cofilin- homology, and a highly acidic (VCA) domain. The V motif
bindsmonomeric G-actin, whereas the CAmotif binds directly to
the Arp2/3 complex (Figure 1A).
The activity ofWASP andN-WASP on Arp2/3 complex is auto-
inhibited by an intramolecular interaction between the GBD and
the C-helix in the VCA domain (Kim et al., 2000). This autoinhibi-
tion can be relieved by the binding of several intracellular ligands,
including Rho family small GTPases Cdc42 and Rac1, PIP2, and
SH2 and SH3 domain-containing proteins, such as Src, Nck, and
Grb2. These intracellular activators bind to WASP and N-WASP
in a way that destabilizes the globular interaction between the
GBD and the C-helix in the VCA domain, enabling the VCA
domain to be released from the GBD and thus enable interaction
with both actin and the Arp2/3 complex (Tomasevic et al., 2007)
(Figure 1B).
Some bacterial pathogens are capable of subverting the actin
polymerization mechanism of their hosts to create actin-based
motility. These pathogens appear to promote actin polymeriza-
tion by exploiting the Arp2/3 complex pathway, but interestingly
each pathogen has evolved a slightly different strategy to do so.
For instance EPEC, Vaccinia virus, and Shigella flexneri recruit
N-WASP and activate it through its natural activators. In
contrast, Listeria monocytogenes and Rickettsia produce
proteins that mimic the function of WASP and N-WASP. Recent
Figure 1. Schematic Representation of the WASP Family
(A) The functional domains of WASP and their interacting proteins (circles).
(B) The activity of WASP on Arp2/3 complex is autoinhibited by an intramolec-
ular interaction between the GBD and the C-helix of the VCA domain. Intracel-
lular activators of WASP, such as Cdc42, bind to GBD and destabilize the
globular interaction between the GBD and the C-helix in the VCA domain,
thus releasing the VCA domain to interact with actin and the Arp2/3 complex.16 Structure 17, January 14, 2009 ª2009 Elsevier Ltd All rights reserstudies in EHEC have revealed a novel and surprisingly simple
strategy to modulate actin rearrangement, as discussed below.
Subversion of Actin Polymerization by EPEC
The main mechanism by which EPEC manipulates actin poly-
merization is through activation of the Nck pathway (Gruenheid
et al., 2001). The Nck dependent pathway is triggered by phos-
phorylation of Tir on tyrosine 474 (Y474) located within the
C-terminal cytoplasmic domain, by host kinases. This generates
a docking site for the mammalian adaptor proteins Nck1 and
Nck2 (collectively termed ‘‘Nck’’). Tyrosine at position 474
is phosphorylated in EPEC strain E2348/69 but can be found
in different Tir positions in other EPEC strains. Nck proteins
contain three N-terminal Src homology 3 (SH3) domains,
followed by a single C-terminal SH2 domain (Lehmann et al.,
1990). The SH2 domain of Nck binds specific tyrosine phosphor-
ylated sites on activated receptors and scaffolds, whereas the
SH3 domains bind to proline-rich motifs of downstream effec-
tors, such as members of the WASP/WAVE family (Moreau
et al., 2000), p21-activated kinase, and many more effectors
(reviewed in Buday et al., 2002). Actin polymerization and
pedestal formation in EPEC begins upon binding of the SH2
domain of Nck to the phosphorylated Y474 of Tir, which then
allows Nck to bind the proline-rich region of N-WASP through
its SH3 domains. This disrupts the autoinhibition of N-WASP,
leading to activated N-WASP, and subsequent activation of the
Arp2/3 complex.
Tyrosine phosphorylation of Tir is mediated by host cell
kinases, but the identity of these enzymes is controversial. The
Src family kinase c-Fyn has been reported to be both necessary
and sufficient for pedestal formation (Phillips et al., 2004).
However, in different studies EPEC Tir was reported to interact
with SH3 domains of redundant kinases, and cells lacking Src,
Fyn, and Yes kinases still formed pedestals (Swimm et al.,
2004a, 2004b).
A second, less efficient, mechanism for actin rearrangement
and pedestal formation is the Nck-independent pathway. This
pathway requires a second C-terminal tyrosine residue in Tir
(Y454 in EPEC strain E2348/69) that is inefficiently phosphory-
lated (Campellone and Leong, 2005). Actin polymerization using
two tyrosines resembles the pathway performed by the Vaccinia
virus A36R protein, which recruits two different adaptor proteins
(Nck and Grb2) to each tyrosine residue (Frischknecht et al.,
1999). This leads to the general concept that Y454 of EPEC Tir
utilizes a second adaptor protein. It has been shown that the
second adaptor protein is not Grb2, because this protein does
not bind to phosphorylated Y454 in EPEC Tir (Campellone and
Leong, 2005) and has yet to be identified.
Novel Strategy for Actin Rearrangement Revealed
in EHEC
EPEC and EHEC pedestals are morphologically similar;
however, several findings indicate that these structures are
not formed by identical biochemical mechanisms. First, in
contrast to EPEC Tir, EHEC Tir lacks the essential Y474.
Second, actin polymerization triggered by EHEC was found to
be Nck independent, as demonstrated in cells deficient for
both Nck1 and Nck2 (Campellone et al., 2002; Gruenheid
et al., 2001). Most importantly, it was shown that EHEC Tir isved
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in an EPECDtir mutant (DeVinney et al., 2001; Kenny, 2001).
Recently, the bacterial effector protein, EspFu (E. coli secreted
protein F-like protein from prophage U, also known as TccP), has
been shown to be needed for pedestal formation in EHEC (Cam-
pellone et al., 2004; Garmendia et al., 2004). Although EspFu is
encoded outside of the LEE, it is delivered into mammalian cells
by the LEE-encoded type III secretion apparatus. Expressing
EspFu in an EPECDtir strain that expresses EHEC Tir causes
formation of pedestals, in contrast to EPECDtir which expresses
EHEC Tir only. This indicates that EspFu is the only EHEC-
specific effector that is required for actin polymerization
(Campellone et al., 2004).
EspFu is composed of an N-terminal type III secretion signal
(80 amino acids in length), which is necessary for secretion
and translocation of the protein into the host cells, followed by
two to seven nearly identical proline-rich repeats (47 amino acids
in length). The repeats share little sequence homology with other
proteins, except for the related EspF protein.
EspFu was suggested to activate the host WASP family of
actin-nucleation proteins, which are normally activated by
Cdc42 and PIP2. Previous studies have shown that EspFu can
interact with the GBD domain of N-WASP (Garmendia et al.,
2006; Lommel et al., 2004) and, therefore, was assumed to
activate N-WASP bymimicking Cdc42. However, a recent study
has shown that EspFu has a novel mechanism to activate
N-WASP by binding directly to the autoinhibitory portion of
GBD, but not to its Cdc42-binding region (Sallee et al., 2008)
(Figure 2). This is the first report of such a straightforward mech-
anism for N-WASP activation, and is especially interesting
because no equivalent host pathway is known. In addition,
EspFu was shown to activate N-WASP but not other
Figure 2. Structure of the N-WASP GBD in
Complex with Different Activators Based on
the NMR Structure (Protein Data Bank entry
1EJ5)
The autoinhibitory complex of GBD-C-helix is
composed of three stacked structural layers
(Cheng et al., 2008). Layer one is shown in brown
(N-terminal GBD), layer two in light brown (C-
terminal GBD), and the C-helix of the catalytic
domain in purple. The natural activators of
N-WASP, Cdc42 and SH2 domains, were shown
to relieve the autoinhibition by binding to layer
one and layer two, respectively, of the complex.
EspFu, however, represents a novel mechanism
because it relieves the autoinhibition by mimicking
the structure of the C-helix (layer three) and, there-
fore, competing for binding to GBD.
Cdc42-responsive proteins, such as the
p21-activated kinases, indicating speci-
ficity. The precise interaction between
the proteins was mapped to the first 17
amino acids of each EspFu repeat and
to residues 228–270 of the N-WASP
GBD (Sallee et al., 2008).
The N-WASP GBD is largely unstruc-
tured on its own, but folds into a well-
defined helical conformation upon
binding to the amphipathic C-helix in the VCA region (Kim
et al., 2000). Under normal conditions, N-WASP is autoinhi-
bited by the interaction between the GBD and the C-helix.
Binding of Cdc42 to GBD disrupts this interaction and
releases the catalytic domain to activate the Arp2/3 complex.
Cheng et al. showed that the binding between one EspFu
repeat and GBD induces folding of both EspFu and GBD.
The NMR structure of WASP GBD in complex with an
N-terminal 33-residue fragment of an EspFu repeat (R33)
revealed three stacked structural layers (Cheng et al., 2008),
which are highly similar to the GBD-C-helix complex. EspFu
R33 forms an analogous amphipathic helix to the C-helix of
the VCA domain and both helices bind the GBD at the same
site and orientation through analogous hydrophobic interac-
tions (Cheng et al., 2008) (Figure 2). The C-terminal residues
of one EspFu repeat (resembles an arm) make additional
contacts with the GBD, which are not present in the bound
C-helix in autoinhibited WASP. This contributes to the higher
affinity of EspFu to the GBD region of WASP compared with
its eukaryotic counterparts. These results indicate that the
N-terminal part of the EspFu repeats mimics the C-helix of
N-WASP and, most importantly, its higher affinity toward the
GBD enables EspFu to displace N-WASP from its endogenous
regulators in vivo. According to Salle et al., two to seven
repeats of EspFu can simultaneously bind and activate
multiple N-WASP proteins, ensuring a high potency of this
bacterial activator.
Sequence alignment of the C-helix and the first 17 amino-
acids of each EspFu repeat revealed a sequence homology at
three positions, all of which contain hydrophobic residues. Muta-
tion of any of the conserved amino acids on either the C-helix or
the EspFu fragment completely disrupted interaction with GBDStructure 17, January 14, 2009 ª2009 Elsevier Ltd All rights reserved 17
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residues are lying at the center of the interface between
C-helix/EspFu and the GBD autoinhibitory element.
Based on the structural and biochemical data, it was
concluded that the EspFu repeat mimics the C-helix of the
N-WASP catalytic domain (which is naturally inhibited by
GBD), and thus disrupts the autoinhibition of N-WASP by
competitively binding to the GBD. EspFu provides a unique
strategy for a pathogen to manipulate host cell signaling; it
does not mimic the natural upstream activators (such as
Cdc42), but rather mimics the autoinhibitory element found
within N-WASP. This allows a selective activation of actin poly-
merization and not other Cdc42-activated pathways.
A short sequence in the C terminus of EHEC Tir, which spans
residues 452–463, was found to be critical for EHEC Tir to recruit
EspFu to sites of EHEC adherence and initiate actin polymeriza-
tion (Allen-Vercoe et al., 2006; Campellone et al., 2006). The
importance of this region was demonstrated by the full comple-
mentation of an EHEC Dtirmutant for actin pedestal formation in
cells expressing a Tir derivative containing the N-terminal
cytoplasmic domain, the extracellular domain, and only the
12-amino-acid region (452–463) of the C-terminal cytoplasmic
domain (Campellone et al., 2006). Brady et al. identified a motif
within this region, designated as NPY, which is particularly crit-
ical for pedestal formation. Mutations in any of the amino acids
of the motif resulted in diminishing pedestal formation. Interest-
ingly, Y458 of EHEC Tir is homologous to EPEC Tir Y454, which
is also part of a NPY motif, raising the possibility that the Nck-
independent pathways of EHEC and EPEC might be related.
The fact that introduction of EspFu into EPEC dramatically
enhanced Nck-independent actin assembly in an NPY depen-
dent manner (Brady et al., 2007) further supports the possibility
that EHEC and EPEC share a common Nck-independent mech-
anism for actin polymerization.
It is known that EspFu, N-WASP, and Tir are part of the same
complex as they can be co-immunoprecipitated from infected
host cells (Brady et al., 2007). However, no direct interaction
has been detected between EHEC Tir and EspFu. Interestingly,
a recent study has shown that Cortactin is recruited to sites of
EHEC attachment and is part of the Tir/EspFu complex (Cantar-
elli et al., 2007). Phosporylated Cortactin might link Tir and EspFu
by simultaneously binding Tir, through its N terminus, and EspFu
with its SH3 domain.
Discussion
Pathogens have evolved several ways of subverting actin poly-
merization in host cells as part of their pathogenic strategies.
Above we have summarized recent progress in our under-
standing of themechanism bywhich E. colimodifies the intracel-
lular host actin-cytoskeleton network from its extracellular
position. Although host and pathogenic N-WASP activators
globally destabilize the autoinhibitory domain of N-WASP, EspFu
activates N-WASP by competing directly for binding to the auto-
inhibitory domain of the protein. This mode represents a simple
strategy in exploiting N-WASP, which enables activation of
a specific pathway. Many pathogens utilize cellular pathways
by mimicking host proteins and, therefore, it will be interesting
to find an equivalent mode of N-WASP activation by a host cell
protein.18 Structure 17, January 14, 2009 ª2009 Elsevier Ltd All rights reseAlthough the mechanism of N-WASP activation by EspFu is
now known (Cheng et al., 2008; Sallee et al., 2008), there are still
some gaps in our knowledge. A recent study revealed that
Cortactin is involved in the Tir/EspFu complex; however, it is
unknown whether additional host proteins need to be recruited
to this complex.
New studies shed light on how EPEC and EHEC proteins
interact with host components; however, the physiological
significance of actin polymerization and how it benefits the
bacteria is not completely clear. Several studies have shown
that there is no direct correlation between actin polymerization,
cell attachment, pedestal formation, effacement of the brush
border microvilli, and bacterial colonization in vivo (Bai et al.,
2008; Deng et al., 2003). However, different pathogens have
developed different strategies to manipulate actin polymeriza-
tion. Moreover, many EPEC strains employing the Nck-
dependent pathway (mostly those that belong to EPEC-2 strains)
and non-O157-EHEC can, additionally and simultaneously, acti-
vate N-WASP via EspFu. These observations suggest that
pedestal formation gives an evolutionary advantage to these
pathogens. At the very least, by studying these pathogenic
mechanisms that have evolved over time by bacteria contacting
mammalian cells, it provides new and alternate ways to
understand and study actin polymerization. Given that evolution
has selected for beneficial mechanisms, by understanding
successful pathogens new insights into cytoskeletal mecha-
nisms and function can be learned.
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